$7.06
0.223.22%
At close: -
$7.06
-0.0001000.00%
After Hours: 6:59 PM EDT
Candel Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Candel Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2024-03-28 | $-0.38 | $-0.16 | -137.5 % |
Q3 | 2023-11-09 | $-0.29 | $-0.19 | -52.6 % |
Q2 | 2023-08-10 | $-0.33 | $-0.30 | -10.0 % |
Q1 | 2023-05-11 | $-0.30 | $-0.35 | 14.3 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2024-03-28 | $0 | $10.00K | -100.0 % |
Q4 | 2023-03-30 | $31.00K | $20.00K | 55.0 % |
Q3 | 2022-11-10 | $31.00K | $30.00K | 3.33 % |
Q4 | 2022-03-29 | $31.00K | $10.00K | 210.0 % |
Candel Therapeutics (CADL) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-0.33, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.